Previous Close | 2.78 |
1-Year Change | -39.57% |
6-Months Change | -18.24% |
3-Months Change | -11.18% |
Moving Avg (50d) | 2.6986 |
Moving Avg (200d) | 2.9394 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 18.5M |
Beta (3-Years) | 0.74 |
Revenue Growth (ttm) | 152.9% |
Net Profit Margin (ttm) | 39.06% |
Return On Assets (ttm) | 40.65% |
EPS (ttm) | 6.17 |
PE Ratio (ttm) | 0.45 |
Dividend Yield | % |
Asset Description: | MEI Pharma, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-07-22 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
3.244 | 3.144 | 3.078 | 2.979 | 2.813 | 2.648 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.